Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1215355.RA5fYDZC4F-20_5iK-vB4KFh2oyt3wg6Vuu7GIuwP-hmA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1215355.RA5fYDZC4F-20_5iK-vB4KFh2oyt3wg6Vuu7GIuwP-hmA130_assertion type Assertion NP1215355.RA5fYDZC4F-20_5iK-vB4KFh2oyt3wg6Vuu7GIuwP-hmA130_head.
- NP1215355.RA5fYDZC4F-20_5iK-vB4KFh2oyt3wg6Vuu7GIuwP-hmA130_assertion description "[Aberrant epidermal growth factor receptor (EGFR) signaling in non-small cell lung cancer (NSCLC) is linked to tumor progression, metastasis and poor survival rates.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215355.RA5fYDZC4F-20_5iK-vB4KFh2oyt3wg6Vuu7GIuwP-hmA130_provenance.
- NP1215355.RA5fYDZC4F-20_5iK-vB4KFh2oyt3wg6Vuu7GIuwP-hmA130_assertion evidence source_evidence_literature NP1215355.RA5fYDZC4F-20_5iK-vB4KFh2oyt3wg6Vuu7GIuwP-hmA130_provenance.
- NP1215355.RA5fYDZC4F-20_5iK-vB4KFh2oyt3wg6Vuu7GIuwP-hmA130_assertion SIO_000772 25174397 NP1215355.RA5fYDZC4F-20_5iK-vB4KFh2oyt3wg6Vuu7GIuwP-hmA130_provenance.
- NP1215355.RA5fYDZC4F-20_5iK-vB4KFh2oyt3wg6Vuu7GIuwP-hmA130_assertion wasDerivedFrom befree-2016 NP1215355.RA5fYDZC4F-20_5iK-vB4KFh2oyt3wg6Vuu7GIuwP-hmA130_provenance.
- NP1215355.RA5fYDZC4F-20_5iK-vB4KFh2oyt3wg6Vuu7GIuwP-hmA130_assertion wasGeneratedBy ECO_0000203 NP1215355.RA5fYDZC4F-20_5iK-vB4KFh2oyt3wg6Vuu7GIuwP-hmA130_provenance.